Contrary to what many of us might assume, it would appear that the ups and downs of romantic relationships take a greater emotional toll on young men than women, according to new research from the US…
No Comments »
Filed under: Women's Health
Although victories by prominent female candidates prompted claims of a “year of the woman” on Tuesday, in at least five major races, the candidates’ gender and “traditional women’s issues” were not significant factors, the Washington Post reports…
No Comments »
Filed under: Women's Health
On Wednesday, Alaska Senate President Gary Stevens (R) said is it “unlikely” that lawmakers could obtain enough votes to override Gov. Sean Parnell’s (R) veto of funding that would have expanded Denali KidCare, a program that covers health care costs for low-income women and children, the Anchorage Daily News reports…
No Comments »
Filed under: Women's Health
As women’s health advocates, researchers and policymakers from around the world meet in Washington, D.C., this week for the Women Deliver conference, the “issue of maternal health has risen to the top of the international development agenda,” NPR’s “Morning Edition” reports. An estimated 340,000 maternal deaths occur annually, according to “Morning Edition…
No Comments »
Filed under: Women's Health
Several female candidates from both parties won contested primaries for state-level and national offices Tuesday, the Washington Post reports (Balz, Washington Post, 6/9). According to CQ Today, as the result of Carly Fiorina’s victory in the Republican primary for the U.S…
No Comments »
Filed under: Women's Health
Claims that the development of a drug to treat female sexual dysfunction amounts to “disease mongering” come “down to a delicate judgment call — that lack of female sexual satisfaction isn’t really a problem,” Washington Post columnist Katrina vanden Heuvel writes…
No Comments »
Filed under: Women's Health
SILVER SPRING, Md. (MedPage Today) — An FDA advisory panel agreed Thursday that fingolimod, the first oral drug for relapsing-remitting multiple sclerosis, appeared to be safe and effective for treating the disease.
No Comments »
Filed under: General Health News
SILVER SPRING, Md. (MedPage Today) — An FDA advisory panel agreed Thursday that fingolimod, the first oral drug for relapsing-remitting multiple sclerosis, appeared to be safe and effective for treating the disease.
No Comments »
Filed under: Pharmacy News
Idenix Pharmaceuticals, Inc., a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral diseases, today announced that it has initiated a 3-day proof-of-concept study of IDX320, a protease inhibitor for the treatment of hepatitis C virus (HCV) infection, under a Clinical Trial Application (CTA). The study is evaluating [...]
No Comments »
Filed under: Pharmacy News
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to the investigation of COL-172 for the relief of moderate to severe pain in patients requiring continuous, around-the-clock opioid treatment for an extended period of time.
No Comments »
Filed under: Pharmacy News
